Please Wait...

'Intelligent Monitoring' Gains Momentum as Pharma Industry Seeks to Realize Risk-Based Monitoring Benefits

─ BioClinica Technology Reduces Risk, Raises Quality in Clinical Trials ─

November 20, 2014

NEWTOWN, PENNSYLVANIA, Nov. 20, 2014 – BioClinica®, Inc., a leading provider of outsourced clinical trial services and eClinical technologies, reports growing demand for its ‘Intelligent Monitoring’ approach to risk-based monitoring in clinical trials. Intelligent monitoring extends the concept of Risk-Based Monitoring beyond merely reducing site monitoring visits or changing monitoring methods. It is an approach aimed at reducing risks and increasing overall quality in clinical trials.

“As clinical trial professionals better understand the original intent of risk-based monitoring, which at its core is to reduce and mitigate risks in a clinical trial, they are increasingly turning to Compass technology to help them do that,” said BioClinica Vice President of Innovation, Courtney McBean. “Our unique approach brings together the right people, process, and technology, giving study teams actionable analytics to make better decisions about how their trials are run.”

McBean explained the benefits of intelligent monitoring in a recent webinar: “An Intelligent Approach to Risk-Based Monitoring.” In her presentation she outlined eight key steps for a risk-based monitoring implementation and explained how intelligent monitoring accounts for the factors critical to successful risk-based monitoring. Over 400 registrants from 245 companies and 25 countries signed up for the webinar, which was followed by a lively question and answer session focused on this topic and innovative approaches.  A recording of the webinar is available on demand at www.BioClinica.com.

BioClinica will present more about Intelligent Monitoring at the Scope Summit for Clinical Operations Executives in Orlando, Florida on February 25, 2015 and at the company’s European ‘Trial Blazers’ User Conference in Barcelona, February 24rd – 25th, where Mireille Zerola, Project Team Leader for the implementation of Risk-Based Monitoring (RBM) at Boehringer Ingelheim and member of TransCelerate Biopharma’s RBM work stream, will present on “Putting Risk-Based Monitoring into Practice.”

The flood of interest in our intelligent monitoring approach has been tremendous,” said Steve Boccardo, Senior Vice President of Business Development. “Whether in Barcelona at the recent Partnerships in Clinical Trials, SCDM, or another industry events, sponsors and CROs can’t hear enough about making risk-based monitoring a reality. The interest in Compass is truly remarkable.”

To request a meeting with BioClinica call our hotline at 1-888-392-7456, email sales@bioclinica.com  or complete the online Contact Us form.

About Bioclinica

Bioclinica is a global life science provider that utilizes science and technology to bring clarity to clinical trials – helping companies to develop new life-improving therapies more efficiently and safely. Successful clinical trials require the ability to see key details and uncover hidden insights, and Bioclinica's hundreds of experienced scientific, medical, and domain experts bring unmatched insight across the development lifecycle, from the initial protocol to post-approval. The company's cloud-based offerings include medical imaging and cardiac safety services; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site and patient payments and budget forecasting; pharmacovigilance; trial management; and risk-based monitoring solutions. A true multifaceted partner to trial sponsors and Contract Research Organizations (CROs), Bioclinica offers a global network of research sites and patient recruitment services to provide committed, detail-focused service through all stages of drug development. The company's thousands of employees serve more than 400 pharmaceutical, biotechnology and device organizations – including all the top 20 biopharmaceutical companies and leading CROs – through a network of offices in the U.S., Europe, and Asia.

Learn more about Bioclinica and our Clinical Adjudication and other offerings at www.Bioclinica.com and in the Bioclinica Blog. Follow the latest company news and happenings on LinkedIn and Twitter.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Still time to catch up on summer reading on recent developments in #Alzheimer's Disease Fluid Biomarkers here int t… https://t.co/kyQmz7FxlN
bioclinica (2 days ago)
Our clients have substantial success w #eSource, some spanning well over a decade. Still other organizations remain… https://t.co/UwVs6ajPp4
bioclinica (3 days ago)
Our clients have substantial success w #eSource, some spanning well over a decade. Still some in the industry remai… https://t.co/ASuUvN6xb9
bioclinica (5 days ago)
RT @RfwrightLSL: When Do You Think #BYOD (Bring Your Own Device) Will Become Widely Used To Capture PRO Data In #Clinical #Research? https:…
bioclinica (2 weeks ago)
ICYMI: Our V.P./Head of Neuroscience & Cardiovascular Svcs., Dr. Joyce Suhy, talks about challenges in determining… https://t.co/Lns6B3VPPN
bioclinica (2 weeks ago)
RT @FCR_News_Today: FDA Issues New Guides on Use of Electronic Health Information in #ClinicalTrials. #ClinicalResearch https://t.co/j8LHV2…
bioclinica (2 weeks ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen